Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus: A Randomized Cross-Over Trial

Research output: Contribution to journalJournal articleResearchpeer-review

The incidence of severe hypoglycemia in type 1 diabetes has not decreased over the past decades. New treatment modalities minimizing the risk of hypoglycemic episodes and attenuating hypoglycemic cognitive dysfunction are needed. We studied if treatment with the neuroprotective hormone erythropoietin (EPO) enhances cognitive function during hypoglycemia.
Original languageEnglish
Article numbere59672
JournalP L o S One
Issue number4
Pages (from-to)1-8
Number of pages8
Publication statusPublished - 5 Apr 2013

ID: 45839942